164 related articles for article (PubMed ID: 31515242)
1. Impact of Older Age and Comorbidity on Locoregional and Distant Breast Cancer Recurrence: A Large Population-Based Study.
de Boer AZ; van der Hulst HC; de Glas NA; Marang-van de Mheen PJ; Siesling S; de Munck L; de Ligt KM; Portielje JEA; Bastiaannet E; Liefers GJ
Oncologist; 2020 Jan; 25(1):e24-e30. PubMed ID: 31515242
[TBL] [Abstract][Full Text] [Related]
2. Impact of Comorbidities and Age on Cause-Specific Mortality in Postmenopausal Patients with Breast Cancer.
Derks MGM; van de Velde CJH; Giardiello D; Seynaeve C; Putter H; Nortier JWR; Dirix LY; Bastiaannet E; Portielje JEA; Liefers GJ
Oncologist; 2019 Jul; 24(7):e467-e474. PubMed ID: 30606886
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer mortality of older patients with and without recurrence analysed by novel multi-state models.
de Boer AZ; Bastiaannet E; Schetelig J; de Glas NA; Manevksi D; Putter H; Liefers GJ; de Munck L; Portielje JEA; de Wreede LC
Eur J Cancer; 2022 Oct; 174():212-220. PubMed ID: 36058128
[TBL] [Abstract][Full Text] [Related]
4. The impact of geriatric characteristics and comorbidities on distant metastases and other cause mortality in older women with non-metastatic breast cancer treated with primary endocrine therapy.
Waaijer MEC; Lemij AA; de Boer AZ; Bastiaannet E; van den Bos F; Derks MGM; Kroep JR; Liefers GJ; Portielje JEA; de Glas NA
Breast Cancer Res Treat; 2023 Oct; 201(3):471-478. PubMed ID: 37479944
[TBL] [Abstract][Full Text] [Related]
5. Impact of age on breast cancer mortality and competing causes of death at 10 years follow-up in the adjuvant TEAM trial.
Derks MGM; Bastiaannet E; van de Water W; de Glas NA; Seynaeve C; Putter H; Nortier JWR; Rea D; Hasenburg A; Markopoulos C; Dirix LY; Portielje JEA; van de Velde CJH; Liefers GJ
Eur J Cancer; 2018 Aug; 99():1-8. PubMed ID: 29885375
[TBL] [Abstract][Full Text] [Related]
6. Validation of the 70-gene signature test (MammaPrint) to identify patients with breast cancer aged ≥ 70 years with ultralow risk of distant recurrence: A population-based cohort study.
Noordhoek I; Bastiaannet E; de Glas NA; Scheepens J; Esserman LJ; Wesseling J; Scholten AN; Schröder CP; Elias SG; Kroep JR; Portielje JEA; Kleijn M; Liefers GJ
J Geriatr Oncol; 2022 Nov; 13(8):1172-1177. PubMed ID: 35871138
[TBL] [Abstract][Full Text] [Related]
7. Prediction of Other-Cause Mortality in Older Patients with Breast Cancer Using Comorbidity.
de Boer AZ; Bastiaannet E; Putter H; Marang-van de Mheen PJ; Siesling S; de Munck L; de Ligt KM; Portielje JEA; Liefers GJ; de Glas NA
Cancers (Basel); 2021 Apr; 13(7):. PubMed ID: 33915755
[No Abstract] [Full Text] [Related]
8. Older age and comorbidity in breast cancer: is RT alone the new therapeutic frontier?
La Rocca E; Meneghini E; Lozza L; Fiorentino A; Vitullo A; Giandini C; Bonfantini F; Di Cosimo S; Gennaro M; Sant M; Pignoli E; Valdagni R; De Santis MC
J Cancer Res Clin Oncol; 2020 Jul; 146(7):1791-1800. PubMed ID: 32405744
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of radiotherapy after breast-conserving surgery in older patients with T1-2N0 breast cancer.
de Boer AZ; Bastiaannet E; de Glas NA; Marang-van de Mheen PJ; Dekkers OM; Siesling S; de Munck L; de Ligt KM; Portielje JEA; Liefers GJ
Breast Cancer Res Treat; 2019 Dec; 178(3):637-645. PubMed ID: 31451977
[TBL] [Abstract][Full Text] [Related]
10. Survival and relapse free period of 2926 unselected older breast cancer patients: a FOCUS cohort study.
Kiderlen M; van de Water W; Bastiaannet E; de Craen AJ; Westendorp RG; van de Velde CJ; Liefers GJ
Cancer Epidemiol; 2015 Feb; 39(1):42-7. PubMed ID: 25497904
[TBL] [Abstract][Full Text] [Related]
11. 21-Gene Recurrence Score and Locoregional Recurrence in Node-Positive/ER-Positive Breast Cancer Treated With Chemo-Endocrine Therapy.
Mamounas EP; Liu Q; Paik S; Baehner FL; Tang G; Jeong JH; Kim SR; Butler SM; Jamshidian F; Cherbavaz DB; Sing AP; Shak S; Julian TB; Lembersky BC; Wickerham DL; Costantino JP; Wolmark N
J Natl Cancer Inst; 2017 Jan; 109(4):. PubMed ID: 28122895
[TBL] [Abstract][Full Text] [Related]
12. Risk of loco-regional recurrence and distant metastases of patients with invasive breast cancer up to ten years after diagnosis - results from a registry-based study from Germany.
Holleczek B; Stegmaier C; Radosa JC; Solomayer EF; Brenner H
BMC Cancer; 2019 May; 19(1):520. PubMed ID: 31146706
[TBL] [Abstract][Full Text] [Related]
13. Can Multistate Modeling of Local Recurrence, Distant Metastasis, and Death Improve the Prediction of Outcome in Patients With Soft Tissue Sarcomas?
Posch F; Leitner L; Bergovec M; Bezan A; Stotz M; Gerger A; Pichler M; Stöger H; Liegl-Atzwanger B; Leithner A; Szkandera J
Clin Orthop Relat Res; 2017 May; 475(5):1427-1435. PubMed ID: 28083752
[TBL] [Abstract][Full Text] [Related]
14. Distribution of Locoregional Breast Cancer Recurrence in Relation to Postoperative Radiation Fields and Biological Subtypes.
Adra J; Lundstedt D; Killander F; Holmberg E; Haghanegi M; Kjellén E; Karlsson P; Alkner S
Int J Radiat Oncol Biol Phys; 2019 Oct; 105(2):285-295. PubMed ID: 31212042
[TBL] [Abstract][Full Text] [Related]
15. Evaluating the Age-Based Recommendations for Long-Term Follow-Up in Breast Cancer.
Witteveen A; de Munck L; Groothuis-Oudshoorn CGM; Sonke GS; Poortmans PM; Boersma LJ; Smidt ML; Vliegen IMH; IJzerman MJ; Siesling S
Oncologist; 2020 Sep; 25(9):e1330-e1338. PubMed ID: 32510767
[TBL] [Abstract][Full Text] [Related]
16. Patterns of tumor relapse following mastectomy and adjuvant systemic therapy in patients with axillary lymph node-positive breast cancer. Impact of clinical, histopathologic, and flow cytometric factors.
Pisansky TM; Ingle JN; Schaid DJ; Hass AC; Krook JE; Donohue JH; Witzig TE; Wold LE
Cancer; 1993 Aug; 72(4):1247-60. PubMed ID: 8339215
[TBL] [Abstract][Full Text] [Related]
17. Performing Survival Analyses in the Presence of Competing Risks: A Clinical Example in Older Breast Cancer Patients.
de Glas NA; Kiderlen M; Vandenbroucke JP; de Craen AJ; Portielje JE; van de Velde CJ; Liefers GJ; Bastiaannet E; Le Cessie S
J Natl Cancer Inst; 2016 May; 108(5):. PubMed ID: 26614095
[TBL] [Abstract][Full Text] [Related]
18. Impact of age and comorbidity on treatment of non-small cell lung cancer recurrence following complete resection: A nationally representative cohort study.
Wong ML; McMurry TL; Stukenborg GJ; Francescatti AB; Amato-Martz C; Schumacher JR; Chang GJ; Greenberg CC; Winchester DP; McKellar DP; Walter LC; Kozower BD
Lung Cancer; 2016 Dec; 102():108-117. PubMed ID: 27987578
[TBL] [Abstract][Full Text] [Related]
19. Contralateral breast cancer risk in relation to tumor morphology and age-in which patients is preoperative MRI justified?
de Glas NA; Engels CC; Bastiaannet E; van de Water W; Siesling S; de Craen AJ; van de Velde CJ; Liefers GJ; Merkus JW
Breast Cancer Res Treat; 2015 Feb; 150(1):191-8. PubMed ID: 25677741
[TBL] [Abstract][Full Text] [Related]
20. Association of Locoregional Control With High Body Mass Index in Women Undergoing Breast Conservation Therapy for Early-Stage Breast Cancer.
Bergom C; Kelly T; Bedi M; Saeed H; Prior P; Rein LE; Szabo A; Wilson JF; Currey AD; White J
Int J Radiat Oncol Biol Phys; 2016 Sep; 96(1):65-71. PubMed ID: 27511848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
